Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 195.
A
Acar-Denizli, Nihan;
Horváth, Ildiko-Fanny;
Mandl, Thomas;
Priori, Roberta;
Vissink, Arjan;
Hernandez-Molina, Gabriela;
Armagan, Berkan;
... Sjögren Big Data Consortium, .; + view all
(2020)
Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
Clinical and Experimental Rheumatology
, 38
(4)
pp. 85-94.
|
 |
|
Adams, D;
Ando, Y;
Beirão, JM;
Coelho, T;
Gertz, MA;
Gillmore, JD;
Hawkins, PN;
... Merlini, G; + view all
(2020)
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
Journal of Neurology
10.1007/s00415-019-09688-0.
(In press).
|
|
|
Al-Khelaifi, F;
Abraham, D;
Hingorani, A;
Elrayess, M;
(2020)
Genome-wide association study reveals a novel association between MYBPC3 gene polymorphism, endurance athlete status, aerobic capacity and steroid metabolism.
Frontiers in Genetics
, 11
, Article 595. 10.3389/fgene.2020.00595.
|
|
|
Al-Khelaifi, F;
Diboun, I;
Donati, F;
Botrè, F;
Abraham, D;
Hingorani, A;
Albagha, O;
... Elrayess, MA; + view all
(2020)
Author Correction: Metabolic GWAS of elite athletes reveals novel genetically-influenced metabolites associated with athletic performance.
Scientific Reports
, 10
(1)
, Article 10473. 10.1038/s41598-020-67555-9.
|
|
|
Allanore, Y;
Wung, P;
Soubrane, C;
Esperet, C;
Marrache, F;
Bejuit, R;
Lahmar, A;
... Investigators; + view all
(2020)
A randomised, double-blind, placebo-controlled, 24-
week, phase II, proof-of-concept study of romilkimab
(SAR156597) in early diffuse cutaneous
systemic sclerosis.
Annals of the Rheumatic Diseases
10.1136/annrheumdis-2020-218447.
(In press).
|
|
|
Allen, BD;
Wong, TC;
Bucciarelli-Ducci, C;
Bryant, J;
Chen, T;
Dall'Armellina, E;
Finn, JP;
... Carr, JC; + view all
(2020)
Society for Cardiovascular Magnetic Resonance (SCMR) guidance for re-activation of cardiovascular magnetic resonance practice after peak phase of the COVID-19 pandemic.
Journal of Cardiovascular Magnetic Resonance
, 22
(1)
, Article 58. 10.1186/s12968-020-00654-8.
|
|
|
Alves, MR;
Isenberg, DA;
(2020)
"Mixed connective tissue disease": a condition in search of an identity.
Clinical and Experimental Medicine
10.1007/s10238-020-00606-7.
(In press).
|
|
|
Arbore, G;
Ong, VH;
Costantini, B;
Denton, CP;
Abraham, D;
Placais, L;
Blighe, K;
... Hourcade, DE; + view all
(2020)
Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis.
Cellular & Molecular Immunology
, 17
pp. 1010-1013.
10.1038/s41423-019-0360-8.
|
|
Augusto, JB;
Menacho, K;
Andiapen, M;
Bowles, R;
Burton, M;
Welch, S;
Bhuva, AN;
... Moon, JC; + view all
(2020)
Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19 [version 1; peer review: 1 approved, 1 approved with reservations].
Wellcome Open Research
, 5
, Article 179. 10.12688/wellcomeopenres.16051.1.
|
|
|
Augusto, JB;
Nordin, S;
Vijapurapu, R;
Baig, S;
Bulluck, H;
Castelletti, S;
Alfarih, M;
... Moon, JC; + view all
(2020)
Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.
Circulation: Cardiovascular Imaging
, 13
(3)
, Article e010171. 10.1161/CIRCIMAGING.119.010171.
|
|
B
|
Baggiano, A;
Boldrini, M;
Martinez-Naharro, A;
Kotecha, T;
Petrie, A;
Rezk, T;
Gritti, M;
... Fontana, M; + view all
(2020)
Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
JACC: Cardiovascular Imaging
, 13
(1(1))
pp. 69-80.
10.1016/j.jcmg.2019.03.026.
|
|
Baggiano, A;
Del Torto, A;
Guglielmo, M;
Muscogiuri, G;
Fusini, L;
Babbaro, M;
Collevecchio, A;
... Pontone, G; + view all
(2020)
Role of CMR Mapping Techniques in Cardiac Hypertrophic Phenotype.
Diagnostics
, 10
(10)
, Article 770. 10.3390/diagnostics10100770.
|
|
|
Barber, MRW;
Hanly, JG;
Su, L;
Urowitz, MB;
St Pierre, Y;
Romero-Diaz, J;
Gordon, C;
... Clarke, AE; + view all
(2020)
Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach.
Arthritis Care & Research
, 72
(12)
pp. 1800-1808.
10.1002/acr.24092.
|
|
Beck, D;
Ferrada, MA;
Sikora, KA;
Ombrello, AK;
Collins, JC;
Pei, W;
Balanda, N;
... Grayson, PC; + view all
(2020)
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
The New England Journal of Medicine
, 2020
(383)
pp. 2628-2638.
10.1056/NEJMoa2026834.
|
|
Belot, A;
Rice, GI;
Omarjee, SO;
Rouchon, Q;
Smith, EMD;
Moreews, M;
Tusseau, M;
... Wood, F; + view all
(2020)
Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts.
The Lancet Rheumatology
, 2
(2)
e99-e109.
10.1016/S2665-9913(19)30142-0.
|
|
Benzian-Olsson, N;
Dand, N;
Chaloner, C;
Bata-Csorgo, Z;
Borroni, R;
Burden, AD;
Cooper, HL;
... ERASPEN consortium and the APRICOT and PLUM study team; + view all
(2020)
Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.
JAMA Dermatology
, 156
(11)
pp. 1216-1222.
10.1001/jamadermatol.2020.3275.
|
|
|
Blagojevic, J;
Abignano, G;
Avouac, J;
Cometi, L;
Frerix, M;
Bellando-Randone, S;
Guiducci, S;
... EUSTAR co-workers, .; + view all
(2020)
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.
Clinical Rheumatology
, 39
pp. 27-36.
10.1007/s10067-019-04564-8.
|
|
Boldrini, M;
Cappelli, F;
Chacko, L;
Restrepo-Cordoba, MA;
Lopez-Sainz, A;
Giannoni, A;
Aimo, A;
... Fontana, M; + view all
(2020)
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis.
JACC: Cardiovascular Imaging
, 13
(4)
pp. 909-920.
10.1016/j.jcmg.2019.10.011.
|
|
Bossini-Castillo, L;
Villanueva-Martin, G;
Kerick, M;
Acosta-Herrera, M;
López-Isac, E;
Simeón, CP;
Ortego-Centeno, N;
... PRECISESADS collaborator group; + view all
(2020)
Genomic Risk Score impact on susceptibility to systemic sclerosis.
Annals of the Rheumatic Diseases
10.1136/annrheumdis-2020-218558.
(In press).
|
|
|
Bou-Gharios, G;
Abraham, D;
de Crombrugghe, B;
(2020)
Type I collagen structure, synthesis, and regulation.
In: Bilezikian, J and Martin, TJ and Rosen, C, (eds.)
Principles of Bone Biology.
(pp. 295-337).
Elsevier: Leiden, The Netherlands.
|
|
Bray, T;
Sakai, N;
Dudek, A;
Fisher, C;
Rajesparan, K;
Lopes, A;
Ciurtin, C;
... Hall-Craggs, M; + view all
(2020)
Histographic Analysis of Oedema and Fat in Inflamed Bone Marrow based on Quantitative MRI.
European Radiology
, 313
10.1007/s00330-020-06785-x.
|
|
|
Brito-Zerón, P;
Acar-Denizli, N;
Ng, W-F;
Horváth, IF;
Rasmussen, A;
Seror, R;
Li, X;
... Sjögren Big Data Consortium; + view all
(2020)
Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.
Rheumatology
, 59
(9)
pp. 2350-2359.
10.1093/rheumatology/kez578.
|
|
Brunner, H;
Abud-Mendoza, C;
Viola, D;
Penades, I;
Levy, D;
Anton, J;
Calderon, J;
... Ruperto, N; + view all
(2020)
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.
Annals of the Rheumatic Diseases
, 79
(10)
pp. 1340-1348.
10.1136/annrheumdis-2020-217101.
|
|
|
Bütikofer, L;
Varisco, PA;
Distler, O;
Kowal-Bielecka, O;
Allanore, Y;
Riemekasten, G;
Villiger, PM;
... EUSTAR collaborators; + view all
(2020)
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.
Arthritis Research & Therapy
, 22
(1)
, Article 59. 10.1186/s13075-020-2141-2.
|
|
C
|
Campanilho-Marques, R;
Deakin, CT;
Simou, S;
Papadopoulou, C;
Wedderburn, LR;
Pilkington, CA;
Juvenile Dermatomyositis Research Group (JDRG);
(2020)
Retrospective analysis of infliximab and
adalimumab treatment in a large cohort of
juvenile dermatomyositis patients.
Arthritis Research & Therapy
, 22
(1)
, Article 79. 10.1186/s13075-020-02164-5.
|
|
|
Canetti, D;
Rendell, NB;
Gilbertson, JA;
Botcher, N;
Nocerino, P;
Blanco, A;
Di Vagno, L;
... Taylor, GW; + view all
(2020)
Diagnostic amyloid proteomics: experience of the UK National Amyloidosis Centre.
Clinical Chemistry and Laboratory Medicine
, 58
(6)
pp. 948-957.
10.1515/cclm-2019-1007.
|
|
Carneiro, AC;
Ruiz, MM;
Freitas, S;
Isenberg, D;
(2020)
Comparison of Three Classification Criteria Sets for Systemic Lupus Erythematosus: A Study Looking at Links to Outcome and Mortality.
Arthritis Care & Research
, 72
(11)
pp. 1611-1614.
10.1002/acr.24061.
|
|
Catapano, M;
Vergnano, M;
Romano, M;
Mahil, SK;
Choon, S-E;
Burden, AD;
Young, HS;
... Capon, F; + view all
(2020)
IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis.
Journal of Investigative Dermatology
, 140
(4)
816-826.e3.
10.1016/j.jid.2019.08.444.
|
|
|
Chacko, L;
Martone, R;
Bandera, F;
Lane, T;
Martinez-Naharro, A;
Boldrini, M;
Rezk, T;
... Fontana, M; + view all
(2020)
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.
European Heart Journal
, 41
(14)
pp. 1439-1447.
10.1093/eurheartj/ehz905.
|
|
Chavda, SJ;
Pocock, R;
Cheesman, S;
Lee, K-M;
Dowling, E;
Marks, DJB;
Kyriakou, C;
... Popat, R; + view all
(2020)
Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations.
British Journal of Haematology
10.1111/bjh.16889.
(In press).
|
|
|
Chen, LY;
Keddie, S;
Lunn, MP;
Bomsztyk, J;
Vitsaras, E;
Gupta, R;
D'Sa, S;
(2020)
IgM paraprotein-associated peripheral neuropathy: small CD20-positive B-cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness.
British Journal of Haematology
, 188
(4)
pp. 511-515.
10.1111/bjh.16210.
|
|
Choida, V;
Ciurtin, C;
Bray, T;
Sen, D;
Fisher, C;
Leandro, M;
Hall-Craggs, M;
(2020)
Frequency and site of clinically unsuspected synovitis on whole-body MRI in Juvenile Idiopathic Arthritis.
Presented at: British Society of Rheumatology Annual Conference.
|
|
Choida, V;
Hall-Craggs, M;
Jebson, B;
Leandro, M;
Fisher, C;
Wedderburn, L;
Ciurtin, C;
(2020)
Biomarkers of response to biologic therapy in juvenile idiopathic arthritis.
Frontiers in Pharmacology
10.3389/fphar.2020.635823.
(In press).
|
 |
|
Chung, L;
Spino, C;
McLain, R;
Johnson, SR;
Denton, CP;
Molitor, JA;
Steen, VD;
... Khanna, D; + view all
(2020)
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.
The Lancet Rheumatology
, 2
(12)
e743-e753.
10.1016/S2665-9913(20)30237-X.
|
|
Clark, KEN;
Collas, O;
Lachmann, H;
Singh, A;
Buckley, J;
Bhagani, S;
(2020)
Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series.
Rheumatology Advances in Practice
, 4
(2)
, Article rkaa040. 10.1093/rap/rkaa040.
|
|
|
Clark, KEN;
Denton, CP;
(2020)
The patient knows best: a new self‐reported outcome measure for systemic sclerosis.
British Journal of Dermatology
, 183
(4)
p. 610.
10.1111/bjd.19033.
|
|
Coelewij, L;
Waddington, K;
Robinson, G;
Chocano, E;
McDonnell, T;
Farinha, F;
Peng, J;
... Pineda-Torra, I; + view all
(2020)
Using serum metabolomics analysis to predict sub-clinical atherosclerosis in patients with SLE.
MedRxiv: Cold Spring Harbor, NY, USA.
|
 |
|
Cohen, H;
Cuadrado, MJ;
Erkan, D;
Duarte-Garcia, A;
Isenberg, DA;
Knight, JS;
Ortel, TL;
... Andrade, D; + view all
(2020)
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
Lupus
, 29
(12)
pp. 1571-1593.
10.1177/0961203320950461.
|
|
Cohen, H;
Sayar, Z;
Efthymiou, M;
Gaspar, P;
Richards, T;
Isenberg, D;
(2020)
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome.
The Lancet Haematology
, 7
(8)
e613-e623.
10.1016/S2352-3026(20)30116-2.
|
|
Cohen, OC;
Brodermann, MH;
Blakeney, IJ;
Mahmood, S;
Sachchithanantham, S;
Ravichandran, S;
Law, S;
... Wechalekar, AD; + view all
(2020)
Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.
Amyloid
, 27
(3)
pp. 200-205.
10.1080/13506129.2020.1765768.
|
|
Cohen, OC;
Law, S;
Lachmann, HJ;
Sharpley, F;
Ravichandran, S;
Mahmood, S;
Sachchithanantham, S;
... Wechalekar, AD; + view all
(2020)
The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis.
Blood Cancer Journal
, 10
(5)
, Article 60. 10.1038/s41408-020-0325-2.
|
|
|
Cohen, OC;
Sharpley, F;
Gilbertson, JA;
Wechalekar, AD;
Sachchithanantham, S;
Mahmood, S;
Whelan, CJ;
... Gillmore, JD; + view all
(2020)
The value of screening biopsies in light chain (AL) and transthyretin (ATTR) amyloidosis.
European Journal of Haematology
, 105
(3)
pp. 352-356.
10.1111/ejh.13458.
|
|
Cohen, OC;
Sharpley, F;
Gillmore, JD;
Lachmann, HJ;
Sachchithanantham, S;
Mahmood, S;
Fontana, M;
... Wechalekar, AD; + view all
(2020)
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis.
British Journal of Haematology
, 189
(4)
pp. 643-649.
10.1111/bjh.16401.
|
|
Cohen, OC;
Wechalekar, AD;
(2020)
Systemic amyloidosis: moving into the spotlight.
Leukemia
, 34
(5)
pp. 1215-1228.
10.1038/s41375-020-0802-4.
|
|
Costa Pires, T;
Caparrós-Ruiz, R;
Gaspar, P;
Isenberg, DA;
(2020)
Prevalence and outcome of thrombocytopenia in systemic lupus erythematous: single-centre cohort analysis.
Clinical & Experimental Rheumatology
(In press).
|
|
Cro, S;
Patel, P;
Barker, J;
Burden, DA;
Griffiths, CEM;
Lachmann, HJ;
Reynolds, NJ;
... Cornelius, V; + view all
(2020)
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial.
Trials
, 21
(1)
, Article 158. 10.1186/s13063-020-4103-z.
|
|
D
|
Denton, CP;
Campochiaro, C;
Bruni, C;
Distler, O;
Iagnocco, A;
Matucci Cerinic, M;
(2020)
COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic.
Journal of Scleroderma and Related Disorders
10.1177/2397198320963393.
(In press).
|
|
|
Denton, CP;
Laird, B;
Moros, L;
Flores, JLL;
(2020)
Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysis.
Clinical Rheumatology
10.1007/s10067-020-05063-x.
|
|
|
Denton, CP;
Laird, B;
Moros, L;
Luna Flores, JL;
(2020)
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysis.
Clinical Rheumatology
10.1007/s10067-020-05371-2.
(In press).
|
|
|
Denton, CP;
Ong, VH;
(2020)
Challenges in evidence-based therapy for systemic sclerosis associated interstitial lung disease.
The Lancet Respiratory Medicine
, 8
(3)
pp. 226-227.
10.1016/S2213-2600(20)30012-6.
|
|
Denton, CP;
Yee, P;
Ong, VH;
(2020)
News and failures from recent treatment trials in systemic sclerosis.
European Journal of Rheumatology
10.5152/eurjrheum.2020.19187.
(In press).
|
|
|
Distler, O;
Assassi, S;
Cottin, V;
Cutolo, M;
Danoff, SK;
Denton, CP;
Distler, JHW;
... Maher, TM; + view all
(2020)
Predictors of progression in systemic sclerosis patients with interstitial lung disease.
European Respiratory Journal
, 55
(5)
, Article 1902026. 10.1183/13993003.02026-2019.
|
|
Dorbala, S;
Ando, Y;
Bokhari, S;
Dispenzieri, A;
Falk, RH;
Ferrari, VA;
Fontana, M;
... Bourque, JM; + view all
(2020)
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization.
Journal of Nuclear Cardiology
, 27
pp. 659-673.
10.1007/s12350-019-01761-5.
|
|
Durot, E;
Kanagaratnam, L;
Zanwar, S;
Kastritis, E;
D'Sa, S;
Garcia-Sanz, R;
Tomowiak, C;
... Castillo, JJ; + view all
(2020)
A prognostic index predicting survival in transformed Waldenström macroglobulinemia.
Haematologica
, 106
(11)
10.3324/haematol.2020.262899.
|
E
|
Egiziano, G;
Widdifield, J;
Rahman, A;
Vinet, E;
Moura, CS;
Curtis, JR;
Bernatsky, S;
(2020)
Antiphospholipid Antibody Testing in a General Population Sample from the USA: An Administrative Database Study.
Scientific Reports
, 10
(1)
, Article 3102. 10.1038/s41598-020-59990-5.
|
|
|
Ehrenstein, M;
Greenwood, M;
Shipa, M;
Yeoh, S;
Roussou, E;
Mukerjee, D;
(2020)
Methotrexate reduces withdrawal rates of TNF-inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive.
Annals of the Rheumatic Diseases
, 79
(11)
pp. 1516-1517.
10.1136/annrheumdis-2020-217725.
|
|
Enocsson, H;
Wirestam, L;
Dahle, C;
Padyukov, L;
Jonsen, A;
Urowitz, MB;
Gladmane, DD;
... Sjowall, C; + view all
(2020)
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
Journal of Autoimmunity
, 106
, Article 102340. 10.1016/j.jaut.2019.102340.
|
|
F
|
Farinha, F;
Pepper, RJ;
Oliveira, DG;
McDonnell, T;
Isenberg, DA;
Rahman, A;
(2020)
Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up.
Rheumatology
10.1093/rheumatology/keaa103.
(In press).
|
|
|
Fisher, BA;
Szanto, A;
Ng, WF;
Bombardieri, M;
Posch, MG;
Papas, AS;
Farag, AM;
... Gergely, P; + view all
(2020)
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.
The Lancet Rheumatology
, 2
(3)
e142-e152.
10.1016/S2665-9913(19)30135-3.
|
|
Fontana, M;
Chacko, LA;
Martinez-Naharro, A;
(2020)
Detailed Understating of Cardiac Amyloidosis by CMR: Towards Personalized Medicine.
JACC: Cardiovascular Imaging
, 13
(6)
pp. 1311-1313.
10.1016/j.jcmg.2020.04.013.
|
|
Fontana, M;
Patel, RK;
Martinez-Naharro, A;
(2020)
Atrial Involvement in Cardiac Amyloidosis: Beyond Dilatation.
JACC: CardioOncology
, 2
(5)
pp. 732-734.
10.1016/j.jaccao.2020.11.005.
|
|
|
Freitas, S;
Mozo Ruiz, M;
Costa Carneiro, A;
Isenberg, DA;
(2020)
Why do some patients with systemic lupus erythematosus fail to respond to B-cell depletion using rituximab.
Clinical and Experimental Rheumatology
, 38
pp. 262-266.
|
|
Furtado O' Mahony, L;
Srivastava, A;
Mehta, P;
Ciurtin, C;
(2020)
Are chronic pain syndromes associated with a unique cytokine profile? A systematic review and meta-analysis.
Presented at: British Society of Rheumatology Annual Conference, Virtual.
|
G
|
Gaspar, P;
Cohen, H;
Isenberg, DA;
(2020)
The assessment of patients with the antiphospholipid antibody syndrome: where are we now?
Rheumatology
, 59
(7)
pp. 1489-1494.
10.1093/rheumatology/keaa172.
|
|
Gegg, ME;
Verona, G;
Schapira, AHV;
(2020)
Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons.
Human Molecular Genetics
, Article ddaa085. 10.1093/hmg/ddaa085.
(In press).
|
|
|
Gertz, M;
Adams, D;
Ando, Y;
Beirão, JM;
Bokhari, S;
Coelho, T;
Comenzo, RL;
... Merlini, G; + view all
(2020)
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
BMC Family Practice
, 21
, Article 198. 10.1186/s12875-020-01252-4.
|
|
|
Giannakopoulos, I;
Griffin, M;
Denton, CP;
Butler, PEM;
(2020)
Developing a quantitative tool to evaluate dermal fibrosis in systemic sclerosis patients: a case-control study.
[Letter].
Clinical and Experimental Rheumatology
, 38
(125)
pp. 172-173.
|
|
|
Gibier, J-B;
Gilbertson, JA;
Perbet, R;
Leriche, W;
Truant, S;
Leteurtre, E;
Gillmore, JD;
(2020)
Découverte fortuite d’une atteinte hépatique d’amylose à leukocyte chemotactic factor 2 [Incidental finding of leukocyte cell-derived chemotaxin 2 – Associated amyloidosis in a liver].
Annales de Pathologie
, 40
(6)
pp. 472-477.
10.1016/j.annpat.2020.04.007.
|
|
Griffin, MF;
Jeon, FHK;
Chew, BJW;
Sherief, A;
Denton, CP;
Butler, PEM;
(2020)
Comparison of non-invasive methodologies to assess mouth opening following lipotransfer techniques to reverse oral fibrosis.
[Letter].
Clinical and Experimental Rheumatology
, 38
(125)
p. 184.
|
|
H
|
Halliday, N;
Williams, C;
Kennedy, A;
Waters, E;
Pesenacker, AM;
Soskic, B;
Hinze, C;
... Sansom, DM; + view all
(2020)
CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
Frontiers in Immunology
, 11
, Article 600000. 10.3389/fimmu.2020.600000.
|
|
|
Hanly, JG;
Li, Q;
Su, L;
Urowitz, MB;
Gordon, C;
Bae, S-C;
Romero-Diaz, J;
... Farewell, V; + view all
(2020)
Peripheral nervous system disease in Systemic Lupus Erythematosus: Results from an international, inception cohort study.
Arthritis Rheumatol
, 72
(1)
pp. 67-77.
10.1002/art.41070.
|
|
Hanly, JG;
Urowitz, MB;
Gordon, C;
Bae, S-C;
Romero-Diaz, J;
Sanchez-Guerrero, J;
Bernatsky, S;
... Farewell, V; + view all
(2020)
Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach.
Annals of the Rheumatic Diseases
, 79
(3)
pp. 356-362.
10.1136/annrheumdis-2019-216150.
|
|
Hässler, S;
Bachelet, D;
Duhaze, J;
Szely, N;
Gleizes, A;
Hacein-Bey Abina, S;
Aktas, O;
... ABIRISK consortium; + view all
(2020)
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
PLoS Medicine
, 17
(10)
, Article e1003348. 10.1371/journal.pmed.1003348.
|
|
|
Herrick, AL;
Griffiths-Jones, DJ;
Ryder, WD;
Mason, JC;
Denton, CP;
(2020)
Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS).
Journal of Scleroderma and Related Disorders
10.1177/2397198320957552.
(In press).
|
|
|
Hong, Y;
Keylock, A;
Jensen, B;
Jacques, TS;
Ogunbiyi, O;
Omoyinmi, E;
Saunders, D;
... Eleftheriou, D; + view all
(2020)
Cerebral arteriopathy associated with heterozygous variants in the casitas B-lineage lymphoma gene.
Neurology Genetics
, 6
(4)
, Article e448. 10.1212/NXG.0000000000000448.
|
|
|
Hughes, M;
Alcacer-Pitarch, B;
Allanore, Y;
Baron, M;
Boin, F;
Bruni, C;
Chung, L;
... Matucci-Cerinic, M; + view all
(2020)
Digital ulcers: should debridement be a standard of care in systemic sclerosis?
The Lancet Rheumatology
, 2
(5)
e302-e307.
10.1016/S2665-9913(19)30164-X.
|
|
Hughes, M;
Allanore, Y;
Chung, L;
Pauling, JD;
Denton, CP;
Matucci-Cerinic, M;
(2020)
Raynaud phenomenon and digital ulcers in systemic sclerosis.
Nature Reviews Rheumatology
, 16
pp. 208-221.
10.1038/s41584-020-0386-4.
|
|
Hughes, M;
Pauling, JD;
Armstrong-James, L;
Denton, CP;
Galdas, P;
Flurey, C;
(2020)
Gender-related differences in systemic sclerosis.
Autoimmunity Reviews
, 19
(4)
, Article 102494. 10.1016/j.autrev.2020.102494.
|
|
Hughes, M;
Pauling, JD;
Jones, J;
Denton, CP;
Domsic, RT;
Frech, TM;
Herrick, AL;
... Moore, A; + view all
(2020)
A Multi-Centre Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic Sclerosis.
Arthritis Care and Research
, 72
(5)
pp. 723-733.
10.1002/acr.24127.
|
|
Hughes, M;
Pauling, JD;
Jones, J;
Denton, CP;
Domsic, RT;
Frech, TM;
Herrick, AL;
... Moore, A; + view all
(2020)
Patient experiences of digital ulcer development and evolution in systemic sclerosis.
Rheumatology
, 59
(8)
pp. 2156-2158.
10.1093/rheumatology/keaa037.
|
|
Hussain, SB;
Botelho, J;
Machado, V;
Zehra, SA;
Mendes, JJ;
Ciurtin, C;
Orlandi, M;
(2020)
Is there a bidirectional association between rheumatoid arthritis and periodontitis? A systematic review and meta-analysis.
Seminars in Arthritis and Rheumatism
, 50
(3)
pp. 414-422.
10.1016/j.semarthrit.2020.01.009.
|
I
|
Inaugural Amyloidosis Forum Panelists, .;
Lousada, I;
(2020)
The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis.
Orphanet Journal of Rare Diseases
, 15
(1)
, Article 268. 10.1186/s13023-020-01525-2.
|
|
|
Isenberg, D;
(2020)
Eric Bywaters a life story: 1 June 1910 to 2 April 2003.
Annals of the Rheumatic Diseases
, 79
(8)
pp. 996-998.
10.1136/annrheumdis-2020-217153.
|
|
|
Isenberg, DA;
Kao, AH;
Aydemir, A;
Merrill, JT;
(2020)
Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders.
Frontiers in Immunology
, 11
, Article 592639. 10.3389/fimmu.2020.592639.
|
|
J
|
Jaeger, VK;
Tikly, M;
Xu, D;
Siegert, E;
Hachulla, E;
Airò, P;
Valentini, G;
... EUSTAR co-authors; + view all
(2020)
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study.
Rheumatology
, 59
(7)
pp. 1684-1694.
10.1093/rheumatology/kez486.
|
|
Jensen, B;
James, R;
Hong, Y;
Omoyinmi, E;
Pilkington, C;
Sebire, NJ;
Howell, KJ;
... Eleftheriou, D; + view all
(2020)
A case of Myhre syndrome mimicking juvenile scleroderma.
Pediatric Rheumatology
, 18
(1)
, Article 72. 10.1186/s12969-020-00466-1.
|
|
|
Jeon, FHK;
Griffin, M;
Denton, CP;
Butler, PEM;
(2020)
Feasibility study of stem-cell enriched autologous lipotransfer to treat oro-facial fibrosis in systemic sclerosis (Sys-Stem): Protocol for open-label randomised controlled trial.
International Journal of Surgery Protocols
, 23
pp. 6-10.
10.1016/j.isjp.2020.07.002.
|
|
|
Jimenez-Royo, P;
Bombardieri, M;
Ciurtin, C;
Kostapanos, M;
Tappuni, AR;
Jordan, N;
Saleem, A;
... Tarzi, R; + view all
(2020)
Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome.
Rheumatology
10.1093/rheumatology/keaa624.
(In press).
|
|
|
John, CR;
Watson, D;
Russ, D;
Goldmann, K;
Ehrenstein, M;
Pitzalis, C;
Lewis, M;
(2020)
M3C: Monte Carlo reference-based consensus clustering.
Scientific Reports
, 10
, Article 1816. 10.1038/s41598-020-58766-1.
|
|
|
Jones, A;
Ciurtin, C;
Kazkaz, H;
Hall-Craggs, M;
(2020)
MAGNETIC RESONANCE IMAGING OF THE SACROILIAC JOINTS IN PATIENTS WITH HYPERMOBILITY: A RETROSPECTIVE COHORT STUDY.
Presented at: EULAR 2020: European Congress of Rheumatology 2020.
|
|
|
Judge, DP;
Kristen, AV;
Grogan, M;
Maurer, MS;
Falk, RH;
Hanna, M;
Gillmore, J;
... Hawkins, PN; + view all
(2020)
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Cardiovascular Drugs and Therapy
10.1007/s10557-019-06919-4.
|
K
|
Kastritis, E;
Leleu, X;
Arnulf, B;
Zamagni, E;
Cibeira, MT;
Kwok, F;
Mollee, P;
... Palladini, G; + view all
(2020)
Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis.
Journal of Clinical Oncology
, 38
(28)
pp. 3252-3260.
10.1200/JCO.20.01285.
|
|
Kastritis, E;
Wechalekar, A;
Schoenland, S;
Sanchorawala, V;
Merlini, G;
Palladini, G;
Minnema, M;
... Dimopoulos, MA; + view all
(2020)
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic.
British Journal of Haematology
, 190
(3)
pp. 346-357.
10.1111/bjh.16898.
|
|
Keddie, S;
Foldes, D;
Caimari, F;
Baldeweg, SE;
Bomsztyk, J;
Ziff, OJ;
Fehmi, J;
... Lunn, MP; + view all
(2020)
Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
Neurology
, 95
(3)
e268-e279.
10.1212/WNL.0000000000009940.
|
|
Keddie, S;
Nagendran, A;
Cox, T;
Bomsztyk, J;
Jaunmuktane, Z;
Brandner, S;
Manji, H;
... Lunn, MP; + view all
(2020)
Peripheral nerve neurolymphomatosis: clinical features, treatment and outcomes.
Muscle & Nerve
, 62
(5)
pp. 617-625.
10.1002/mus.27045.
|
|
Keenan, CM;
Ramos-Mucci, L;
Kanakis, I;
Milner, PI;
Leask, A;
Abraham, D;
Bou-Gharios, G;
(2020)
Post-traumatic osteoarthritis development is not modified by postnatal chondrocyte deletion of Ccn2.
Disease Models & Mechanisms
, 13
(7)
, Article dmm044719. 10.1242/dmm.044719.
|
|
|
Khanna, D;
Allanore, Y;
Denton, CP;
Kuwana, M;
Matucci-Cerinic, M;
Pope, JE;
Atsumi, T;
... Distler, O; + view all
(2020)
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial.
Annals of the Rheumatic Diseases
, 79
(5)
pp. 618-625.
10.1136/annrheumdis-2019-216823.
|
|
|
Khanna, D;
Lin, CJF;
Furst, DE;
Goldin, J;
Kim, G;
Kuwana, M;
Allanore, Y;
... focuSSced investigators; + view all
(2020)
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet Respiratory Medicine
, 8
(10)
pp. 963-974.
10.1016/S2213-2600(20)30318-0.
|
|
Khanna, D;
Spino, C;
Johnson, S;
Chung, L;
Whitfield, M;
Denton, CP;
Berrocal, V;
... Furst, DE; + view all
(2020)
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis - Results of a Phase 2 Investigator-Initiated, Multicenter, Double-Blind Randomized Placebo-Controlled Trial.
Arthritis and Rheumatology
, 72
(1)
pp. 125-136.
10.1002/art.41055.
|
|
Khawaja, AA;
Chong, DLW;
Sahota, J;
Mikolasch, TA;
Pericleous, C;
Ripoll, VM;
Booth, HL;
... Porter, JC; + view all
(2020)
Identification of a Novel HIF-1α-α_{M}β_{2} Integrin-NET Axis in Fibrotic Interstitial Lung Disease.
Frontiers in Immunology
, 11
, Article 2190. 10.3389/fimmu.2020.02190.
|
|
|
Knight, DS;
Kotecha, T;
Razvi, Y;
Chacko, L;
Brown, JT;
Jeetley, PS;
Goldring, J;
... Fontana, M; + view all
(2020)
COVID-19: Myocardial injury in survivors.
Circulation
10.1161/CIRCULATIONAHA.120.049252.
|
|
Kolev, M;
West, EE;
Kunz, N;
Chauss, D;
Moseman, EA;
Rahman, J;
Freiwald, T;
... Kemper, C; + view all
(2020)
Diapedesis-Induced Integrin Signaling via LFA-1 Facilitates Tissue Immunity by Inducing Intrinsic Complement C3 Expression in Immune Cells.
Immunity
, 52
(3)
513-527.e8.
10.1016/j.immuni.2020.02.006.
|
|
Kotecha, T;
Chacko, L;
Chehab, O;
O'Reilly, N;
Martinez-Naharro, A;
Lazari, J;
Knott, KD;
... Fontana, M; + view all
(2020)
Assessment of Multivessel Coronary Artery Disease Using Cardiovascular Magnetic Resonance Pixelwise Quantitative Perfusion Mapping.
JACC: Cardiovascular Imaging
, 13
(12)
pp. 2546-2557.
10.1016/j.jcmg.2020.06.041.
|
L
|
Lam, SD;
Bordin, N;
Waman, VP;
Scholes, HM;
Ashford, P;
Sen, N;
van Dorp, L;
... Orengo, CA; + view all
(2020)
SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals.
Scientific Reports
, 10
, Article 16471. 10.1038/s41598-020-71936-5.
|
|
|
Law, S;
Gillmore, J;
Gilbertson, JA;
Bass, P;
Salama, AD;
(2020)
Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis.
BMC Nephrology
, 21
(1)
, Article 74. 10.1186/s12882-020-01733-9.
|
|
|
Law, S;
Petrie, A;
Chacko, L;
Cohen, OC;
Ravichandran, S;
Gilbertson, JA;
Rowczenio, D;
... Gillmore, JD; + view all
(2020)
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.
ESC Heart Failure
10.1002/ehf2.12989.
(In press).
|
|
Legge, A;
Kirkland, S;
Rockwood, K;
Andreou, P;
Bae, S-C;
Gordon, C;
Romero-Diaz, J;
... Hanly, JG; + view all
(2020)
Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI).
Arthritis & Rheumatology
, 72
(4)
pp. 658-666.
10.1002/art.41144.
|
|
Li, W;
Lazarus, A;
Gao, H;
Martinez-Naharro, A;
Fontana, M;
Hawkins, P;
Biswas, S;
... Luo, X; + view all
(2020)
Analysis of Cardiac Amyloidosis Progression Using Model-Based Markers.
Frontiers in Physiology
, 11
, Article 324. 10.3389/fphys.2020.00324.
|
|
|
Liz, MA;
Coelho, T;
Bellotti, V;
Fernandez-Arias, MI;
Mallaina, P;
Obici, L;
(2020)
A Narrative Review of the Role of Transthyretin in Health and Disease.
Neurology and Therapy
10.1007/s40120-020-00217-0.
(In press).
|
|
|
Lorenzo-Vizcaya, A;
Fasano, S;
Isenberg, DA;
(2020)
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?
ImmunoTargets and Therapy
, 9
pp. 105-110.
10.2147/ITT.S240874.
|
|
|
Luong, S-N;
Isaacs, A;
Sin, FE;
Giles, I;
(2020)
A systematic review and meta-analysis of the gonadotoxic effects of cyclophosphamide and benefits of gonadotropin releasing hormone agonists (GnRHa) in women of child-bearing age with autoimmune rheumatic disease.
Expert Review of Clinical Immunology
, 16
(3)
pp. 321-333.
10.1080/1744666X.2020.1724091.
|
|
Lynn, M;
Goulden, B;
Parmar, M;
Knopp, P;
Yeung, M;
Giles, I;
Davies, C;
... Davis, D; + view all
(2020)
Play attention! Therapeutic aspects to play in delirium prevention and management [version 1; peer review: 1 approved].
Wellcome Open Research
, 5
, Article 277. 10.12688/wellcomeopenres.16199.1.
|
|
M
|
Mahmoud, K;
Zayat, A;
Yusof, MYM;
Ciurtin, C;
Yee, CS;
Isenberg, D;
Teh, LS;
... Vital, E; + view all
(2020)
USEFUL II: DERIVATION OF THE LUPUS ARTHRITIS AND MUSCULOSKELETAL DISEASE ACTIVITY SCORE (LAMDA) USING DATA FROM A MULTICENTRE LONGITUDINAL STUDY.
Presented at: EULAR 2020: European Congress of Rheumatology 2020.
|
|
|
Mahmoud, K;
Zayat, A;
Yusof, MYM;
Dutton, K;
Teh, LS;
Yee, CS;
D'cruz, D;
... Vital, E; + view all
(2020)
USEFUL STUDY I: A MULTICENTRE LONGITUDINAL STUDY TO TEST WHETHER ULTRASOUND CAN IDENTIFY PATIENTS WITH MUSCULOSKELETAL SYMPTOMS OF LUPUS WITH BETTER RESPONSE TO THERAPY.
Presented at: EULAR 2020: European Congress of Rheumatology 2020.
|
|
Mahmoud, K;
Zayat, AS;
Md Yusof, MY;
Dutton, K;
Teh, LS;
Yee, C-S;
D’Cruz, D;
... Vital, EM; + view all
(2020)
P193 USEFUL I: musculoskeletal ultrasound to identify patients with lupus arthritis with better response to therapy.
Presented at: 12th European Lupus Meeting.
|
|
Manson, JJ;
Crooks, C;
Naja, M;
Ledlie, A;
Goulden, B;
Liddle, T;
Khan, E;
... Tattersall, RS; + view all
(2020)
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.
The Lancet Rheumatology
, 2
(10)
e594-e602.
10.1016/S2665-9913(20)30275-7.
|
|
Martinez-Naharro, A;
Baksi, AJ;
Hawkins, PN;
Fontana, M;
(2020)
Diagnostic imaging of cardiac amyloidosis.
Nature Reviews Cardiology
, 17
pp. 413-426.
10.1038/s41569-020-0334-7.
|
  |
|
Massias, JS;
Smith, EMD;
Al-Abadi, E;
Armon, K;
Bailey, K;
Ciurtin, C;
Davidson, J;
... Hedrich, CM; + view all
(2020)
Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
Lupus
10.1177/0961203320909156.
(In press).
|
|
|
Matucci-Cerinic, M;
Bruni, C;
Allanore, Y;
Clementi, M;
Dagna, L;
Damjanov, NS;
de Paulis, A;
... Taliani, G; + view all
(2020)
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.
Annals of the Rheumatic Diseases
10.1136/annrheumdis-2020-217407.
(In press).
|
|
|
McGowan, CR;
Wright, T;
Nitsch, D;
Lewer, D;
Brathwaite, R;
Scott, J;
Hope, V;
... Harris, M; + view all
(2020)
High prevalence of albuminuria amongst people who inject drugs: A cross-sectional study.
Scientific Reports
, 10
, Article 7059. 10.1038/s41598-020-63748-4.
|
|
|
Mehta, P;
Ciurtin, C;
Scully, M;
Levi, M;
Chambers, RC;
(2020)
JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.
European Respiratory Journal
, 56
(3)
, Article 2001919. 10.1183/13993003.01919-2020.
|
|
|
Mehta, P;
Porter, JC;
Chambers, RC;
Isenberg, DA;
Reddy, V;
(2020)
B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?
The Lancet Rheumatology
, 2
(10)
e589-e590.
10.1016/S2665-9913(20)30270-8.
|
|
Migdalska-Richards, A;
Wegrzynowicz, M;
Harrison, IF;
Verona, G;
Bellotti, V;
Spillantini, MG;
Schapira, AHV;
(2020)
L444P Gba1 mutation increases formation and spread of α-synuclein deposits in mice injected with mouse α-synuclein pre-formed fibrils.
PLoS One
, 15
(8)
, Article e0238075. 10.1371/journal.pone.0238075.
|
|
|
Milani, P;
Sharpley, F;
Schoenland, SO;
Basset, M;
Mahmood, S;
Nuvolone, M;
Kimmich, C;
... Hegenbart, U; + view all
(2020)
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patients.
The Journal of Protein Folding Disorders
, 27
(4)
pp. 231-236.
10.1080/13506129.2020.1767566.
|
|
Moezinia, CJ;
Ji-Xu, A;
Azari, A;
Horlick, S;
Denton, C;
Stratton, R;
(2020)
Iloprost for COVID-19-related vasculopathy.
The Lancet Rheumatology
, 2
(10)
e582-e583.
10.1016/S2665-9913(20)30232-0.
|
|
Mohamed, M;
Gardeitchik, T;
Balasubramaniam, S;
Guerrero-Castillo, S;
Dalloyaux, D;
van Kraaij, S;
Venselaar, H;
... Wevers, RA; + view all
(2020)
Novel defect in phosphatidylinositol 4‐kinase type 2‐alpha (PI4K2A) at the membrane‐enzyme interface is associated with metabolic cutis laxa.
Journal of Inherited Metabolic Disease
10.1002/jimd.12255.
(In press).
|
|
|
Moinzadeh, P;
Frommolt, P;
Franitza, M;
Toliat, MR;
Becker, K;
Nürnberg, P;
Nihtyanova, SI;
... Krieg, T; + view all
(2020)
Whole blood gene expression profiling distinguishes systemic sclerosis-overlap syndromes from other subsets.
Journal of the European Academy of Dermatology and Venereology
, 34
(5)
e236-e238.
10.1111/jdv.16198.
|
|
Morand, EF;
Isenberg, DA;
Wallace, DJ;
Kao, AH;
Vazquez-Mateo, C;
Chang, P;
Pudota, K;
... Merrill, JT; + view all
(2020)
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.
Rheumatology
, Article keaa029. 10.1093/rheumatology/keaa029.
(In press).
|
|
|
Moura, A;
Nocerino, P;
Gilbertson, JA;
Rendell, NB;
Mangione, PP;
Verona, G;
Rowczenio, D;
... Canetti, D; + view all
(2020)
Lysozyme amyloid: evidence for the W64R variant by proteomics in the absence of the wild type protein.
[Letter].
Amyloid
10.1080/13506129.2020.1720637.
(In press).
|
|
|
Muller, P;
Chowdhury, K;
Gordon, C;
Ehrenstein, MR;
Doré, CJ;
(2020)
Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan.
Trials
, 21
, Article 652. 10.1186/s13063-020-04391-2.
|
|
|
Murphy, G;
Isenberg, DA;
(2020)
Biologic therapies for systemic lupus erythematosus: where are we now?
Current Opinion in Rheumatology
, 32
(6)
pp. 597-608.
10.1097/BOR.0000000000000736.
|
N
|
Nagaraja, V;
Cerinic, M-M;
Furst, DE;
Kuwana, M;
Allanore, Y;
Denton, CP;
Raghu, G;
... Khanna, D; + view all
(2020)
Current and future outlook on disease modification and defining low disease activity in systemic sclerosis.
Arthritis and Rheumatology
, 72
(7)
pp. 1049-1058.
10.1002/art.41246.
|
|
Naja1, M;
Wedderburn, L;
Ciurtin, C;
(2020)
COVID-19 infection in children and adolescents.
British Journal of Hospital Medicine
pp. 1-10.
10.12968/hmed.2020.0321.
(In press).
|
|
|
Ng, KW;
Faulkner, N;
Cornish, GH;
Rosa, A;
Harvey, R;
Hussain, S;
Ulferts, R;
... Kassiotis, G; + view all
(2020)
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Science
, Article eabe1107. 10.1126/science.abe1107.
(In press).
|
|
|
Ngcozana, T;
Ong, VH;
Denton, CP;
(2020)
Improving access to digital ulcer care through nurse-led clinic: a service evaluation.
Musculoskeletal Care
, 18
(1)
pp. 92-97.
10.1002/msc.1433.
|
|
Nihtyanova, SI;
Denton, CP;
(2020)
Pathogenesis of systemic sclerosis associated interstitial lung disease.
Journal of Scleroderma and Related Disorders
, 5
(S2)
pp. 6-16.
10.1177/2397198320903867.
|
|
|
Nihtyanova, SI;
Sari, A;
Harvey, JC;
Leslie, A;
Derrett-Smith, EC;
Fonseca, C;
Ong, VH;
(2020)
Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis.
Arthritis & Rheumatology
, 72
(3)
pp. 465-476.
10.1002/art.41153.
|
O
|
Obici, L;
Berk, JL;
González-Duarte, A;
Coelho, T;
Gillmore, J;
Schmidt, HH-J;
Schilling, M;
... Adams, D; + view all
(2020)
Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.
Amyloid
10.1080/13506129.2020.1730790.
(In press).
|
|
|
Oláh, C;
Schwartz, N;
Denton, C;
Kardos, Z;
Putterman, C;
Szekanecz, Z;
(2020)
Cognitive dysfunction in autoimmune rheumatic diseases.
Arthritis Research & Therapy
, 22
, Article 78. 10.1186/s13075-020-02180-5.
|
|
|
Oldham, J;
Lachmann, HJ;
(2020)
The systemic autoinflammatory disorders for dermatologists. Part 1: overview.
Clinical and Experimental Dermatology
10.1111/ced.14250.
(In press).
|
|
|
Oldham, J;
Lachmann, HJ;
(2020)
The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples.
Clinical and Experimental Dermatology
10.1111/ced.14251.
(In press).
|
|
|
Orlandi, M;
D'Aiuto, F;
Porter, SR;
Ciurtin, C;
(2020)
The Mouth and Lupus.
In:
Lupus: Diagnosis and Treatment.
(pp. 1-17).
Lupus UK: Romford, UK.
|
|
Orteu, CH;
Ong, VH;
Denton, CP;
(2020)
Scleroderma mimics – Clinical features and management.
Best Practice & Research Clinical Rheumatology
, 34
(1)
, Article 101489. 10.1016/j.berh.2020.101489.
|
P
|
Palladini, G;
Kastritis, E;
Maurer, MS;
Zonder, JA;
Minnema, MC;
Wechalekar, AD;
Jaccard, A;
... Comenzo, RL; + view all
(2020)
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA.
Blood
, 136
(1)
pp. 71-80.
10.1182/blood.2019004460.
|
|
Papa, R;
Gilbertson, JA;
Rendell, N;
Wechalekar, AD;
Gillmore, JD;
Hawkins, PN;
Lachmann, HJ;
(2020)
Two types of systemic amyloidosis in a single patient.
Amyloid
, 27
(4)
pp. 275-276.
10.1080/13506129.2020.1760238.
|
|
Pathak, S;
Rowczenio, D;
Lara-Reyna, S;
Kacar, M;
Owen, R;
Doody, G;
Krause, K;
... Savic, S; + view all
(2020)
Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome.
Frontiers in Immunology
, 11
, Article 569006. 10.3389/fimmu.2020.569006.
|
|
|
Peckham, H;
de Gruijter, NM;
Raine, C;
Radziszewska, A;
Ciurtin, C;
Wedderburn, LR;
Rosser, EC;
... Deakin, CT; + view all
(2020)
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.
Nature Communications
, 11
, Article 6317. 10.1038/s41467-020-19741-6.
|
|
|
Portou, MJ;
Yu, R;
Baker, D;
Xu, S;
Abraham, D;
Tsui, J;
(2020)
Hyperglycaemia and Ischaemia Impair Wound Healing via Toll-like Receptor 4 Pathway Activation in vitro and in an Experimental Murine Model.
European Journal of Vascular and Endovascular Surgery
, 59
(1)
pp. 117-127.
10.1016/j.ejvs.2019.06.018.
|
R
|
Rahman, A;
(2020)
Management of antiphospholipid syndrome.
Clinical Rheumatology
, 39
pp. 2111-2114.
10.1007/s10067-020-05183-4.
|
|
Rahman, A;
(2020)
Unusual presentations in patients with systemic lupus erythematosus: a result of disease activity or something else?
British Journal of Hospital Medicine
, 81
(4)
10.12968/hmed.2020.0120.
|
|
Raimondi, S;
Mangione, PP;
Verona, G;
Canetti, D;
Nocerino, P;
Marchese, L;
Piccarducci, R;
... Bellotti, V; + view all
(2020)
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils.
Journal of Biological Chemistry
, 295
(33)
pp. 11379-11387.
10.1074/jbc.RA120.014026.
|
|
|
Ravichandran, S;
Lachmann, HJ;
Wechalekar, AD;
(2020)
Epidemiologic and Survival Trends in Amyloidosis, 1987–2019.
The New England Journal of Medicine
, 382
(16)
pp. 1567-1568.
10.1056/NEJMc1917321.
|
|
Reynolds, CJ;
Swadling, L;
Gibbons, JM;
Pade, C;
Jensen, MP;
Diniz, MO;
Schmidt, NM;
... Boyton, RJ; + view all
(2020)
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.
Science Advances
, 5
(54)
, Article eabf3698. 10.1126/sciimmunol.abf3698.
|
|
Robinson, GA;
Peng, J;
Dönnes, P;
Coelewij, L;
Naja, M;
Radziszewska, A;
Wincup, C;
... Jury, EC; + view all
(2020)
Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach.
The Lancet Rheumatology
, 2
(8)
e485-e496.
10.1016/s2665-9913(20)30168-5.
|
|
|
Romano, M;
Piskin, D;
Berard, RA;
Jackson, BC;
Acikel, C;
Carrero, JJ;
Lachmann, HJ;
... Demirkaya, E; + view all
(2020)
Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis.
Scientific Reports
, 10
, Article 18374. 10.1038/s41598-020-75433-7.
|
|
|
Roofeh, D;
Distler, O;
Allanore, Y;
Denton, CP;
Khanna, D;
(2020)
Treatment of systemic sclerosis associated ILD: Lessons from clinical trials.
Journal of Scleroderma and Related Disorders
, 5
(2 Suppl)
pp. 61-71.
10.1177/2397198320903208.
|
|
|
Rosser, EC;
Piper, CJM;
Matei, DE;
Blair, PA;
Rendeiro, AF;
Orford, M;
Alber, DG;
... Mauri, C; + view all
(2020)
Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells.
Cell Metabolism
10.1016/j.cmet.2020.03.003.
(In press).
|
|
|
Rowczenio, DM;
Youngstein, T;
Trojer, H;
Omoyinmi, E;
Baginska, A;
Brogan, P;
Papadopoulou, C;
... Lachmann, HJ; + view all
(2020)
British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature.
Rheumatology
, 59
(3)
pp. 554-558.
10.1093/rheumatology/kez334.
|
S
|
Saracino, Amanda;
(2020)
The molecular aetiopathogenesis of adult morphoea.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Saracino, AM;
George, C;
Nihtyanova, SI;
Denton, CP;
(2020)
Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre.
Journal of Scleroderma and Related Disorders
10.1177/2397198320925684.
(In press).
|
|
|
Sauna, ZE;
Richards, SM;
Maillere, B;
Jury, EC;
Rosenberg, AS;
(2020)
Editorial: Immunogenicity of Proteins Used as Therapeutics.
Frontiers in Immunology
, 11
, Article 614856. 10.3389/fimmu.2020.614856.
|
|
|
Schreiber, K;
Sciascia, S;
Bruce, IN;
Giles, I;
Cuadrado, MJ;
Cohen, H;
Gordon, C;
... Hunt, BJ; + view all
(2020)
Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians.
The Lancet Rheumatology
10.1016/S2665-9913(20)30382-9.
(In press).
|
|
|
Scully, PR;
Morris, E;
Patel, KP;
Treibel, TA;
Burniston, M;
Klotz, E;
Newton, JD;
... Menezes, LJ; + view all
(2020)
DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker.
JACC: Cardiovascular Imaging
, 13
(6)
pp. 1353-1363.
10.1016/j.jcmg.2020.03.020.
|
|
|
Scully, PR;
Patel, KP;
Saberwal, B;
Klotz, E;
Augusto, JB;
Thornton, GD;
Hughes, RK;
... Pugliese, F; + view all
(2020)
Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients.
JACC: Cardiovasc Imaging
10.1016/j.jcmg.2020.05.029.
(In press).
|
|
|
Scully, PR;
Patel, KP;
Treibel, TA;
Thornton, GD;
Hughes, RK;
Chadalavada, S;
Katsoulis, M;
... Moon, JC; + view all
(2020)
Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.
European Heart Journal
10.1093/eurheartj/ehaa170.
(In press).
|
|
|
Sethi, S;
Nast, CC;
D'Agati, VD;
Fervenza, FC;
Glassock, RJ;
Stokes, MB;
De Vriese, AS;
... Haas, M; + view all
(2020)
Standardized reporting of monoclonal immunoglobulin-associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group.
Kidney International
, 98
(2)
pp. 310-313.
10.1016/j.kint.2020.03.025.
|
|
Sharpley, FA;
De-Silva, D;
Mahmood, S;
Sachchithanantham, S;
Ramsay, I;
Garcia Mingo, A;
Worthington, S;
... D Wechalekar, A; + view all
(2020)
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.
European Journal of Haematology
, 104
(3)
pp. 230-235.
10.1111/ejh.13366.
|
|
Sharpley, FA;
Fontana, M;
Gilbertson, JA;
Gillmore, JD;
Hawkins, PN;
Mahmood, S;
Manwani, R;
... Lachmann, HJ; + view all
(2020)
Amyloidosis Diagnosed in Solid Organ Transplant Recipients.
Transplantation
, 104
(2)
pp. 415-420.
10.1097/TP.0000000000002813.
|
|
Shinar, Y;
Ceccherini, I;
Rowczenio, D;
Aksentijevich, I;
Arostegui, J;
Ben-Chétrit, E;
Boursier, G;
... Touitou, I; + view all
(2020)
ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era.
Clinical Chemistry
, 66
(4)
pp. 525-536.
10.1093/clinchem/hvaa024.
|
|
|
Shoop-Worrall, SJW;
Hyrich, KL;
Wedderburn, LR;
Thomson, W;
Geifman, N;
Baildam, E;
Barnes, M;
... Yarwood, A; + view all
(2020)
Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study.
The Lancet Rheumatology
10.1016/s2665-9913(20)30269-1.
(In press).
|
|
|
Shovlin, C;
Simeoni, I;
Downes, K;
Frazer, Z;
Megy, K;
Bernabéu-Herrero, M;
Shurr, AYL;
... Turro, E; + view all
(2020)
Mutational and phenotypic characterisation of hereditary hemorrhagic telangiectasia.
Blood
, 136
(17)
pp. 1907-1918.
10.1182/blood.2019004560.
|
|
Sillitoe, I;
Bordin, N;
Dawson, N;
Waman, VP;
Ashford, P;
Scholes, HM;
Pang, CSM;
... Orengo, CA; + view all
(2020)
CATH: increased structural coverage of functional space.
Nucleic Acids Research
10.1093/nar/gkaa1079.
(In press).
|
|
|
Smith, V;
Herrick, AL;
Ingegnoli, F;
Damjanov, N;
Angelis;
Denton, CP;
Distler, O;
... EULAR Study Group on Microcirculation in Rheumatic Diseases and; + view all
(2020)
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis.
Autoimmunity Reviews
, Article 102458. 10.1016/j.autrev.2020.102458.
(In press).
|
|
Soskic, B;
Jeffery, LE;
Kennedy, A;
Gardner, DH;
Hou, TZ;
Halliday, N;
Williams, C;
... Sansom, DM; + view all
(2020)
CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis.
Frontiers Immunology
, 11
, Article 577655. 10.3389/fimmu.2020.577655.
|
|
|
Standing, AS;
Hong, Y;
Paisan-Ruiz, C;
Omoyinmi, E;
Medlar, A;
Stanescu, H;
Kleta, R;
... Brogan, PA; + view all
(2020)
TRAP1 chaperone protein mutations and autoinflammation.
Life Science Alliance
, 3
(2)
, Article e201900376. 10.26508/lsa.201900376.
|
|
|
Stern, EP;
Guerra, SG;
Chinque, H;
Acquaah, V;
González-Serna, D;
Ponticos, M;
Martin, J;
... Denton, CP; + view all
(2020)
Analysis of anti-RNA polymerase III antibody positive systemic sclerosis suggests altered GPATCH2L and CTNND2 expression in scleroderma renal crisis.
The Journal of Rheumatology
, 47
(3)
, Article 190945. 10.3899/jrheum.190945.
|
|
Stock, CJ;
Conti, C;
Montero-Fernandez, Á;
Caramori, G;
Molyneaux, PL;
George, PM;
Kokosi, M;
... Renzoni, EA; + view all
(2020)
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?
Thorax
10.1136/thoraxjnl-2020-214579.
(In press).
|
|
|
Stock, CJW;
De Lauretis, A;
Visca, D;
Daccord, C;
Kokosi, M;
Kouranos, V;
Margaritopoulos, G;
... Renzoni, EA; + view all
(2020)
Defining genetic risk factors for scleroderma-associated interstitial lung disease.
Clinical Rheumatology
10.1007/s10067-019-04922-6.
(In press).
|
|
|
Stratton, R;
Taki, Z;
Denton, C;
Ahmed Abdi, B;
(2020)
Pathogenic Activation of Mesenchymal Stem Cells is induced by the Disease Microenvironment in Systemic Sclerosis.
Arthritis and Rheumatology
, 72
(8)
pp. 1361-1374.
10.1002/art.41267.
|
T
|
Treibel, TA;
Manisty, C;
Andiapen, M;
Pade, C;
Jensen, M;
Fontana, M;
Couto-Parada, X;
... Moon, JC; + view all
(2020)
Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply.
The Lancet
, 396
(10260)
pp. 1394-1395.
10.1016/S0140-6736(20)32211-X.
|
|
|
Tucker, L;
Ciurtin, C;
(2020)
Sjogren's syndrome and Ig G4 disease.
In: Petty, R and Laxer, R and Lindsley, C and Wedderburn, L and Fuhlbrigge, R and Mellins, E, (eds.)
Textbook of Pediatric Rheumatology.
Elsevier: Amsterdam, The Netherlands.
|
|
Tufan, A;
Lachmann, H;
(2020)
Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review.
Turkish Journal of Medical Sciences
, 2020
(50)
pp. 1591-1610.
10.3906/sag-2008-11.
|
|
U
|
Urowitz, MB;
Gladman, DD;
Farewell, V;
Su, J;
Romero-Diaz, J;
Bae, S-C;
Fortin, PR;
... Stoll, T; + view all
(2020)
Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort.
Arthritis & Rheumatology
, 72
(10)
pp. 1734-1740.
10.1002/art.41392.
|
V
|
van Dam, LS;
Osmani, Z;
Kamerling, SWA;
Kraaij, T;
Bakker, JA;
Scherer, HU;
Rabelink, TJ;
... Teng, YKO; + view all
(2020)
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.
Rheumatology
10.1093/rheumatology/kez623.
(In press).
|
|
W
|
Waddington, KE;
Papadaki, A;
Coelewij, L;
Adriani, M;
Nytrova, P;
Kubala Havrdova, E;
Fogdell-Hahn, A;
... Jury, EC; + view all
(2020)
Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ.
Frontiers In Immunology
, 11
, Article 1527. 10.3389/fimmu.2020.01527.
|
|
|
Wechalekar, AD;
Chakraborty, R;
Lentzsch, S;
(2020)
Systemic Amyloidosis due to Low-Grade Lymphoma.
Hematology/Oncology Clinics of North America
, 34
(6)
pp. 1027-1039.
10.1016/j.hoc.2020.08.016.
|
|
Wedderburn, L;
Peckham, H;
De Gruijter, N;
Raine, C;
Radziszewska, A;
Ciurtin, C;
Rosser, E;
... Webb, K; + view all
(2020)
Sex-bias in COVID-19: a meta-analysis and review of sex differences in disease and immunity.
Research Square: Durham, NC, USA.
|
|
Weibel, L;
Theiler, M;
Howell, KJ;
Denton, CP;
Waelchli, R;
Atherton, D;
Woo, P;
(2020)
Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi-modal imaging.
Journal of the European Academy of Dermatology and Venereology
, 34
(7)
pp. 1609-1616.
10.1111/jdv.16308.
|
|
Wilkinson, MGL;
Radziszewska, A;
Wincup, C;
Ioannou, Y;
Isenberg, DA;
Manson, JJ;
Jury, EC;
(2020)
Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies.
Rheumatology
, 59
(1)
pp. 194-204.
10.1093/rheumatology/kez252.
|
|
Wisniowski, B;
Wechalekar, A;
(2020)
Confirming the Diagnosis of Amyloidosis.
Acta Haematologica
, 143
(4)
pp. 312-321.
10.1159/000508022.
|
X
|
Xue, H;
Davies, RH;
Brown, LAE;
Knott, KD;
Kotecha, T;
Fontana, M;
Plein, S;
... Kellman, P; + view all
(2020)
Automated Inline Analysis of Myocardial Perfusion MRI with Deep Learning.
Radiology: Artificial Intelligence
, 2
(6)
, Article e200009. 10.1148/ryai.2020200009.
|
|
|
Xue, H;
Tseng, E;
Knott, KD;
Kotecha, T;
Brown, L;
Plein, S;
Fontana, M;
... Kellman, P; + view all
(2020)
Automated detection of left ventricle in arterial input function images for inline perfusion mapping using deep learning: A study of 15,000 patients.
Magnetic Resonance in Medicine
, 84
(5)
pp. 2788-2800.
10.1002/mrm.28291.
|
Y
|
Yaseen, B;
Lopez, H;
Taki, Z;
Zafar, S;
Rosario, H;
Abdi, BA;
Vigneswaran, S;
... Stratton, R; + view all
(2020)
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma.
Rheumatology
, 59
(9)
pp. 2625-2636.
10.1093/rheumatology/keaa195.
|
|
Yeoh, S-A;
Ehrenstein, MR;
(2020)
Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?
The Lancet Rheumatology
, 2
(8)
e454-e456.
10.1016/S2665-9913(20)30175-2.
|
|
Z
|
Zuily, S;
Cohen, H;
Isenberg, D;
Woller, SC;
Crowther, M;
Dufrost, V;
Wahl, D;
... Devreese, KMJ; + view all
(2020)
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
J Thromb Haemost
, 18
(9)
pp. 2126-2137.
10.1111/jth.14935.
|
